Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Letocha%2C+H.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Letocha%2C+H.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2009
- Contribution to journal Published meeting abstract
Interim analysis of epidermal-growth factor receptor (EGFR) expression in a single-arm, phase II, first-line study (20060314) of panitumumab with FOLFIRI in the management of metastatic colorectal cancer (mCRC)
Koehne, C. ; Hofheinz, R. ; Mineur, L. ; Letocha, H. ; Greil, R. ; Thaler, J. ; Gamelin, E. ; Fernebro, Eva ^LU ; Wright, L. and Karthaus, M. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology In EJC Supplements 7(2). p.343-344 Mark
- Contribution to journal Published meeting abstract
Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
Greil, R. ; Letocha, H. ; Gamelin, E. ; Thaler, J. ; Hofheinz, R. ; Mineur, L. ; Fernebro, Eva ^LU ; Karthaus, M. ; Wright, L. and Koehne, C. (2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15). Mark
2007
- Contribution to journal Article
Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
Albertsson, M. ; Johansson, B. ; Friesland, S. ; Kadar, Lianna ^LU ; Letocha, H. ; Frykholm, G. and Wagenius, G. (2007) In Medical Oncology 24(4). p.407-412 Mark

Lund University Publications

LUND UNIVERSITY LIBRARIES